Stocks
Cardinal Health Financial Statements (CAH) |
||||||||||
| Cardinal Healthsmart-lab.ru | % | 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 20.08.2019 | 13.08.2020 | 16.08.2021 | 11.08.2022 | 15.08.2023 | 02.05.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 145 534 | 152 922 | 162 467 | 181 364 | 205 012 | 220 572 | |||
| Operating Income, bln rub | 2 060 | 1 773 | 1 841 | 1 648 | 727.0 | 1 206 | ||||
| EBITDA, bln rub | ? | 2 718 | 2 686 | 2 624 | 2 340 | 2 466 | 2 816 | |||
| Net profit, bln rub | ? | 1 363 | -3 693 | 611.0 | -932.0 | 261.0 | 552.0 | |||
| OCF, bln rub | ? | 2 722 | 1 960 | 2 429 | 3 122 | 2 839 | 2 592 | |||
| CAPEX, bln rub | ? | 328.0 | 375.0 | 400.0 | 387.0 | 481.0 | 423.0 | |||
| FCF, bln rub | ? | 2 394 | 1 585 | 2 029 | 2 735 | 2 358 | 2 169 | |||
| Dividend payout, bln rub | 577.0 | 569.0 | 573.0 | 559.0 | 525.0 | 381.0 | ||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 42.3% | 0.00% | 93.8% | 0.00% | 201.1% | 69.0% | ||||
| OPEX, bln rub | 5 101 | 5 096 | 4 984 | 4 881 | 5 119 | 5 225 | ||||
| Cost of production, bln rub | 138 700 | 146 054 | 155 689 | 174 819 | 198 123 | 213 248 | ||||
| R&D, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||||
| Interest expenses, bln rub | 294.0 | 238.0 | 180.0 | 149.0 | 93.0 | 70.0 | ||||
| Assets, bln rub | 40 963 | 40 766 | 44 453 | 43 878 | 43 417 | 45 880 | ||||
| Net Assets, bln rub | ? | 6 330 | 1 792 | 1 794 | -706.0 | -2 851 | -3 265 | |||
| Debt, bln rub | 8 031 | 6 775 | 6 236 | 5 315 | 4 701 | 5 854 | ||||
| Cash, bln rub | 2 531 | 2 771 | 3 407 | 4 717 | 4 043 | 3 718 | ||||
| Net debt, bln rub | 5 500 | 4 004 | 2 829 | 598.0 | 658.0 | 2 136 | ||||
| Ordinary share price, rub | 47.1 | 52.2 | 57.1 | 52.3 | 94.6 | 93.8 | ||||
| Number of ordinary shares, mln | 300.0 | 293.0 | 292.0 | 279.0 | 261.0 | 243.0 | ||||
| Market cap, bln rub | 14 130 | 15 292 | 16 670 | 14 583 | 24 683 | 22 791 | ||||
| EV, bln rub | ? | 19 630 | 19 296 | 19 499 | 15 181 | 25 341 | 24 927 | |||
| Book value, bln rub | -5 478 | -9 483 | -8 300 | -8 335 | -8 932 | -14 560 | ||||
| EPS, rub | ? | 4.54 | -12.6 | 2.09 | -3.34 | 1.00 | 2.27 | |||
| FCF/share, rub | 7.98 | 5.41 | 6.95 | 9.80 | 9.03 | 8.93 | ||||
| BV/share, rub | -18.3 | -32.4 | -28.4 | -29.9 | -34.2 | -59.9 | ||||
| EBITDA margin, % | ? | 1.87% | 1.76% | 1.62% | 1.29% | 1.20% | 1.28% | |||
| Net margin, % | ? | 0.94% | -2.41% | 0.38% | -0.51% | 0.13% | 0.25% | |||
| FCF yield, % | ? | 16.9% | 10.4% | 12.2% | 18.8% | 9.55% | 9.52% | |||
| ROE, % | ? | 21.5% | -206.1% | 34.1% | 132.0% | -9.15% | -16.9% | |||
| ROA, % | ? | 3.33% | -9.06% | 1.37% | -2.12% | 0.60% | 1.20% | |||
| P/E | ? | 10.4 | -4.14 | 27.3 | -15.6 | 94.6 | 41.3 | |||
| P/FCF | 5.90 | 9.65 | 8.22 | 5.33 | 10.5 | 10.5 | ||||
| P/S | ? | 0.10 | 0.10 | 0.10 | 0.08 | 0.12 | 0.10 | |||
| P/BV | ? | -2.58 | -1.61 | -2.01 | -1.75 | -2.76 | -1.57 | |||
| EV/EBITDA | ? | 7.22 | 7.18 | 7.43 | 6.49 | 10.3 | 8.85 | |||
| Debt/EBITDA | 2.02 | 1.49 | 1.08 | 0.26 | 0.27 | 0.76 | ||||
| R&D/CAPEX, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0 | ||||
| CAPEX/Revenue, % | 0.23% | 0.25% | 0.25% | 0.21% | 0.23% | 0.19% | ||||
| Cardinal Health shareholders | ||||||||||
